肿瘤科威廉亚洲博彩公司

订阅

MedSci主页 / 所有栏目 / 肿瘤科威廉亚洲博彩公司

2018 ESUR威廉亚洲博彩公司 ：子宫内膜癌MRI分期（更新）

2018-07-11 欧洲泌尿生殖放射学会 Eur Radiol. 2018 Jul 11.

子宫内膜癌MRI分期

2018年7月，欧洲泌尿生殖放射学会(ESUR)更新发布了子宫内膜癌MRI分期威廉亚洲博彩公司 ，该威廉亚洲博彩公司 是对2009年版威廉亚洲博彩公司 的更新，主要目的是为子宫内膜癌MRI分期检查提供标准的影像获取和报告。内容涉及患者准备，MRI影像获得，解释和报告等。

中文标题：

2018 ESUR威廉亚洲博彩公司 ：子宫内膜癌MRI分期（更新）

英文标题：

Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology.

发布机构：

欧洲泌尿生殖放射学会

发布日期：

2018-07-11

简要介绍：

2018年7月，欧洲泌尿生殖放射学会(ESUR)更新发布了子宫内膜癌MRI分期威廉亚洲博彩公司 ，该威廉亚洲博彩公司 是对2009年版威廉亚洲博彩公司 的更新，主要目的是为子宫内膜癌MRI分期检查提供标准的影像获取和报告。内容涉及患者准备，MRI影像获得，解释和报告等。 

拓展威廉亚洲博彩公司 ：与子宫内膜癌相关威廉亚洲博彩公司 ：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 ESUR威廉亚洲博彩公司 ：子宫内膜癌MRI分期（更新）)] GetToolGuiderByIdResponse(projectId=1, id=de3c21c0016158f1, title=2018 ESUR威廉亚洲博彩公司 ：子宫内膜癌MRI分期（更新）, enTitle=Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology., guiderFrom=Eur Radiol. 2018 Jul 11., authorId=null, author=, summary=2018年7月，欧洲泌尿生殖放射学会(ESUR)更新发布了子宫内膜癌MRI分期威廉亚洲博彩公司 ，该威廉亚洲博彩公司 是对2009年版威廉亚洲博彩公司 的更新，主要目的是为子宫内膜癌MRI分期检查提供标准的影像获取和报告。内容涉及患者准备，MRI影像获得，解释和报告等。 , cover=, journalId=null, articlesId=null, associationId=1067, associationName=欧洲泌尿生殖放射学会, associationIntro=null, copyright=0, guiderPublishedTime=Wed Jul 11 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2018年7月，欧洲泌尿生殖放射学会(ESUR)更新发布了子宫内膜癌MRI分期威廉亚洲博彩公司 ，该威廉亚洲博彩公司 是对2009年版威廉亚洲博彩公司 的更新，主要目的是为子宫内膜癌MRI分期检查提供标准的影像获取和报告。内容涉及患者准备，MRI影像获得，解释和报告等。 </div> <div><br> </div>拓展威廉亚洲博彩公司 ：<strong>与<font color=red>子宫内膜癌</font>相关威廉亚洲博彩公司 ：</strong><br><ul><li><a href="//www.nyrain.com/guideline/show_article.do?id=f550d1c0015262de" title="子宫内膜癌筛查和早期诊断专家共识（草案）" target=_blank>子宫内膜癌筛查和早期诊断专家共识（草案）</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=84e111c00133e072" title="2016 KSGO共识声明：子宫内膜癌的管理实践威廉亚洲博彩公司 " target=_blank>2016 KSGO共识声明：子宫内膜癌的管理实践威廉亚洲博彩公司 </a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=2770d1c0013151af" title="2015 ACOG/SGO临床威廉亚洲博彩公司 （NO.149）：子宫内膜癌" target=_blank>2015 ACOG/SGO临床威廉亚洲博彩公司 （NO.149）：子宫内膜癌</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=4d06a1c001215947" title="2015 ESMO/ESGO/ESTRO共识会议：子宫内膜癌的诊断、治疗和随访" target=_blank>2015 ESMO/ESGO/ESTRO共识会议：子宫内膜癌的诊断、治疗和随访</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=ca5b81c001191ed9" title="2015 ASCO/ASRO：子宫内膜癌术后放射治疗循证威廉亚洲博彩公司 " target=_blank>2015 ASCO/ASRO：子宫内膜癌术后放射治疗循证威廉亚洲博彩公司 </a></li> 更多信息请点击：<a href="//www.nyrain.com/guideline/list.do?q=%E5%AD%90%E5%AE%AB%E5%86%85%E8%86%9C%E7%99%8C" target=_blank>有关子宫内膜癌更多威廉亚洲博彩公司 </a></ul>, tagList=[TagDto(tagId=850, tagName=子宫内膜癌), TagDto(tagId=77910, tagName=MRI分期)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=威廉亚洲博彩公司 , guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10713, appHits=400, showAppHits=26, pcHits=6287, showPcHits=5808, likes=134, shares=18, comments=5, approvalStatus=1, publishedTime=Sun Jul 15 22:30:46 CST 2018, publishedTimeString=2018-07-11, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Jul 15 22:30:46 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 20:33:13 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 ESUR威廉亚洲博彩公司 ：子宫内膜癌MRI分期（更新）)])
2018 ESUR威廉亚洲博彩公司 ：子宫内膜癌MRI分期（更新）
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=954472, encodeId=08899544e24d, content=受益匪浅！好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:05:06 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954597, encodeId=981f95459edd, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 13:50:33 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332089, encodeId=abcf332089be, content=不错的文章值得拥有., beContent=null, objectType=guider, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Jul 16 23:03:29 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331903, encodeId=414f33190328, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Jul 16 06:35:37 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331868, encodeId=5a61331868a4, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Sun Jul 15 23:53:27 CST 2018, time=2018-07-15, status=1, ipAttribution=)]
    2021-04-07 湘雅科教

    受益匪浅！好文章。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=954472, encodeId=08899544e24d, content=受益匪浅！好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:05:06 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954597, encodeId=981f95459edd, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 13:50:33 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332089, encodeId=abcf332089be, content=不错的文章值得拥有., beContent=null, objectType=guider, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Jul 16 23:03:29 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331903, encodeId=414f33190328, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Jul 16 06:35:37 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331868, encodeId=5a61331868a4, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Sun Jul 15 23:53:27 CST 2018, time=2018-07-15, status=1, ipAttribution=)]
    2021-04-07 ms6000001015893838

    资料好好，但无法分享，遗憾！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=954472, encodeId=08899544e24d, content=受益匪浅！好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:05:06 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954597, encodeId=981f95459edd, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 13:50:33 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332089, encodeId=abcf332089be, content=不错的文章值得拥有., beContent=null, objectType=guider, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Jul 16 23:03:29 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331903, encodeId=414f33190328, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Jul 16 06:35:37 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331868, encodeId=5a61331868a4, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Sun Jul 15 23:53:27 CST 2018, time=2018-07-15, status=1, ipAttribution=)]
    2018-07-16 1e1b8538m79(暂无匿称)

    不错的文章值得拥有.

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=954472, encodeId=08899544e24d, content=受益匪浅！好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:05:06 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954597, encodeId=981f95459edd, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 13:50:33 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332089, encodeId=abcf332089be, content=不错的文章值得拥有., beContent=null, objectType=guider, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Jul 16 23:03:29 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331903, encodeId=414f33190328, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Jul 16 06:35:37 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331868, encodeId=5a61331868a4, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Sun Jul 15 23:53:27 CST 2018, time=2018-07-15, status=1, ipAttribution=)]
    2018-07-16 yjs木玉

    好好好好好好好好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=954472, encodeId=08899544e24d, content=受益匪浅！好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:05:06 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954597, encodeId=981f95459edd, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 13:50:33 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332089, encodeId=abcf332089be, content=不错的文章值得拥有., beContent=null, objectType=guider, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Jul 16 23:03:29 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331903, encodeId=414f33190328, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Jul 16 06:35:37 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331868, encodeId=5a61331868a4, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Sun Jul 15 23:53:27 CST 2018, time=2018-07-15, status=1, ipAttribution=)]
    2018-07-15 清风拂面

    谢谢分享学习

    0

相关威廉亚洲博彩公司

子宫内膜癌筛查和早期诊断专家共识（草案）

中国肿瘤科相关专家小组（统称） · 2017-10-30

2016 KSGO共识声明：子宫内膜癌的管理实践威廉亚洲博彩公司

暂未更新 · 2016-10-27

2015 ACOG/SGO临床威廉亚洲博彩公司 （NO.149）：子宫内膜癌

美国妇产科医师学会(ACOG,American College of Obstetricians and Gynecologists) · 2015-04-01

2015 ESMO/ESGO/ESTRO共识会议：子宫内膜癌的诊断、治疗和随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2015-12-02

2015 ASCO/ASRO：子宫内膜癌术后放射治疗循证威廉亚洲博彩公司

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2016-05-30